All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 25, 2021
Home » Blogs » BioWorld MedTech Perspectives » Need to track your BMs? Try GIMonitor, a.k.a. Buttbook

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

Need to track your BMs? Try GIMonitor, a.k.a. Buttbook

Dec. 29, 2011
By Amanda Pedersen
No Comments
GIMonitor
GIMonitor by WellApps

Just call me Pinocchio because I lied. Last week I said I would review the Sleep Cycle app for this week’s mobile health review, but over the holiday weekend I came across an app that I am so excited about I just have to tell you about it first. But don’t worry, the Sleep Cycle app is already downloaded on my iPhone and I promise to tell you all about it next week.

For Crohn’s disease or ulcerative colitis patients like me, GIMonitor by WellApps is a must-have mobile app. If I didn’t already own a smartphone I would buy one just for this app alone. I would highly recommend this app to anybody with any type of GI issue or IBD - and best of all, it’s free. I downloaded GIMonitor primarily for the purpose of tracking everything I eat, along with my six-plus daily bowel movements, in order to gain a better understanding of which foods cause problems for me and which foods (if any) are truly safe. This app is a fantastic way to do this.

GIMonitor allows users to track the exact time, consistency and urgency of every bowel movement (BM), every meal, and every symptom that may be directly or indirectly related to their digestive issues. Then it charts the information over a particular time period so the patient and their doctor can look for patterns. Additionally, the app automatically calculates the user’s quality of life on a scale of 1 to 10 based on the frequency and urgency of their BMs, along with any pain or blood associated with it.

Perhaps the best feature GIMonitor offers is a social forum where users are able to share their thoughts and support each other in the battle against Crohn’s, colitis, etc. It’s actually a lot like Facebook for IBD patients and is affectionately referred to among frequent users as Buttbook.

I can’t stress enough how important the social feature of the app is. People who suffer from IBD and related disorders - or any chronic illness for that matter – are often uncomfortable talking about their symptoms with friends and family. After all, describing the frequency and consistency of one’s poop isn’t exactly good dinner conversation. It is incredibly refreshing to be able to connect with real people who truly understand what I go through each day. Just being able to have candid discussions about what goes on in the bathroom is surprisingly rewarding.

I know there are similar mobile apps available for people with other chronic diseases, like diabetes. If those apps even come close to doing for those patients what GIMonitor does for people like me, the developers of such apps should be commended. I only wish I had discovered this app sooner.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Seniors with wooden puzzle

    Cassava’s simufilam improves AD patients’ cognition, behavior

    BioWorld
    When Cassava Sciences Inc.’s president and CEO, Remi Barbier, opened up the interim analysis of the company’s open-label study for Alzheimer’s disease candidate...
  • Vaxart COVID-19 vaccine tablets

    Vaxart shares shaken despite apparently positive early data for oral COVID-19 vaccine

    BioWorld
    Vaxart Inc. investors who stuck by company shares Feb. 3 had to swallow a bitter pill – watching shares of the oral vaccine developer (NASDAQ:VXRT) fall 57.8% to...
  • IPO money

    Lucira Health launches $153M IPO

    BioWorld MedTech
    Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 25.
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing